

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.94742281 |
| 2 | protein neddylation (GO:0045116) | 7.61056300 |
| 3 | adenosine receptor signaling pathway (GO:0001973) | 6.82933982 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.23823784 |
| 5 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.87461262 |
| 6 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.68795372 |
| 7 | regulation of platelet aggregation (GO:0090330) | 5.54086884 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.35881826 |
| 9 | regulation of platelet activation (GO:0010543) | 5.13342337 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.07630935 |
| 11 | regulation of skeletal muscle contraction (GO:0014819) | 4.86293791 |
| 12 | positive regulation of protein homodimerization activity (GO:0090073) | 4.82585570 |
| 13 | blood coagulation, intrinsic pathway (GO:0007597) | 4.81297191 |
| 14 | lipoxygenase pathway (GO:0019372) | 4.80797456 |
| 15 | megakaryocyte development (GO:0035855) | 4.50541159 |
| 16 | purinergic receptor signaling pathway (GO:0035587) | 4.44607655 |
| 17 | negative regulation of norepinephrine secretion (GO:0010700) | 4.44057269 |
| 18 | platelet aggregation (GO:0070527) | 4.27540685 |
| 19 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.14965121 |
| 20 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.11631445 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 4.10444856 |
| 22 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.07640065 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.02384285 |
| 24 | platelet formation (GO:0030220) | 3.99528887 |
| 25 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.97436728 |
| 26 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.97436728 |
| 27 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.94179977 |
| 28 | negative regulation of heart rate (GO:0010459) | 3.91472438 |
| 29 | endothelium development (GO:0003158) | 3.88653277 |
| 30 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.80287407 |
| 31 | ether lipid metabolic process (GO:0046485) | 3.71070534 |
| 32 | regulation of megakaryocyte differentiation (GO:0045652) | 3.67976523 |
| 33 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.63793730 |
| 34 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.63164467 |
| 35 | angiogenesis involved in wound healing (GO:0060055) | 3.59479255 |
| 36 | negative regulation of platelet activation (GO:0010544) | 3.57522876 |
| 37 | cyclooxygenase pathway (GO:0019371) | 3.54650230 |
| 38 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53357557 |
| 39 | granulocyte differentiation (GO:0030851) | 3.46041096 |
| 40 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.45974096 |
| 41 | negative regulation of appetite (GO:0032099) | 3.34854228 |
| 42 | negative regulation of response to food (GO:0032096) | 3.34854228 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.34649845 |
| 44 | negative regulation of cell aging (GO:0090344) | 3.34173100 |
| 45 | neutrophil activation (GO:0042119) | 3.33720582 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.32469058 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.26811302 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23190166 |
| 49 | cardiolipin metabolic process (GO:0032048) | 3.21871698 |
| 50 | deoxyribonucleotide catabolic process (GO:0009264) | 3.21018955 |
| 51 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.18676649 |
| 52 | negative regulation of T cell apoptotic process (GO:0070233) | 3.15569731 |
| 53 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.14341041 |
| 54 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.14340983 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 3.12889920 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.12889920 |
| 57 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.12517012 |
| 58 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.12497322 |
| 59 | deoxyribose phosphate catabolic process (GO:0046386) | 3.09338139 |
| 60 | regulation of integrin activation (GO:0033623) | 3.08350164 |
| 61 | monoamine transport (GO:0015844) | 3.08304906 |
| 62 | polyamine biosynthetic process (GO:0006596) | 3.06866313 |
| 63 | grooming behavior (GO:0007625) | 3.05156628 |
| 64 | reverse cholesterol transport (GO:0043691) | 3.03668445 |
| 65 | regulation of mast cell activation (GO:0033003) | 3.02219072 |
| 66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.02007510 |
| 67 | protein carboxylation (GO:0018214) | 3.02007510 |
| 68 | mitochondrial calcium ion transport (GO:0006851) | 3.00244674 |
| 69 | sialylation (GO:0097503) | 2.97672004 |
| 70 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.96818294 |
| 71 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.95612030 |
| 72 | regulation of lipoprotein metabolic process (GO:0050746) | 2.94577840 |
| 73 | granulocyte activation (GO:0036230) | 2.94356788 |
| 74 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.93007570 |
| 75 | positive regulation of macrophage differentiation (GO:0045651) | 2.92503830 |
| 76 | platelet activation (GO:0030168) | 2.91757151 |
| 77 | platelet degranulation (GO:0002576) | 2.91154502 |
| 78 | meiotic chromosome segregation (GO:0045132) | 2.90052517 |
| 79 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.89773761 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 2.88703636 |
| 81 | adenosine metabolic process (GO:0046085) | 2.88029078 |
| 82 | beta-amyloid metabolic process (GO:0050435) | 2.86105283 |
| 83 | homotypic cell-cell adhesion (GO:0034109) | 2.85338612 |
| 84 | regulation of norepinephrine secretion (GO:0014061) | 2.84205435 |
| 85 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.83977512 |
| 86 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79687078 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.75691312 |
| 88 | purine-containing compound salvage (GO:0043101) | 2.75473732 |
| 89 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.74201710 |
| 90 | leukocyte degranulation (GO:0043299) | 2.73668134 |
| 91 | interkinetic nuclear migration (GO:0022027) | 2.72285117 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 2.72093515 |
| 93 | positive regulation of blood pressure (GO:0045777) | 2.70217464 |
| 94 | amine biosynthetic process (GO:0009309) | 2.69355316 |
| 95 | extracellular fibril organization (GO:0043206) | 2.68564262 |
| 96 | peptide catabolic process (GO:0043171) | 2.68207485 |
| 97 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.66875344 |
| 98 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.66812401 |
| 99 | actin nucleation (GO:0045010) | 2.66540244 |
| 100 | deoxyribose phosphate metabolic process (GO:0019692) | 2.65336763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.74709572 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.21029549 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.14663757 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37189242 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.24583007 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 3.00399593 |
| 7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.85076279 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.79732395 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.70047938 |
| 10 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.66269815 |
| 11 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.64137385 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.54156525 |
| 13 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.43278592 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.37075904 |
| 15 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.35155485 |
| 16 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.32606548 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26838977 |
| 18 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22699171 |
| 19 | GATA2_19941826_ChIP-Seq_K562_Human | 2.07140992 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04162768 |
| 21 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.99816677 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.99784063 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.93321758 |
| 24 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.89826565 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86767370 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85905786 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.85513699 |
| 28 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.82372698 |
| 29 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.79311699 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.78169062 |
| 31 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.78083831 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76086514 |
| 33 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.75089958 |
| 34 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73551672 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.64731973 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58167637 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54044412 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52771716 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52348406 |
| 40 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.51818127 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.47795400 |
| 42 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.46535303 |
| 43 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.45512386 |
| 44 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.45070623 |
| 45 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.44435700 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42749685 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42569270 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.38518981 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34983014 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33638917 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33339703 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30565949 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29777193 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28302019 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27553645 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26935589 |
| 57 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.25567290 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24594946 |
| 59 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23947845 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22560903 |
| 61 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21933184 |
| 62 | P300_27268052_Chip-Seq_Bcells_Human | 1.21126755 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21015032 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.19673432 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18187839 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18002419 |
| 67 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15790932 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15738624 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15492908 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15248152 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14932138 |
| 72 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13153647 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12731619 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08944363 |
| 75 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07705780 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07204608 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07005865 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06197659 |
| 79 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05593856 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05342297 |
| 81 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.04674727 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04381937 |
| 83 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.03425780 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03325696 |
| 85 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03096639 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01884262 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.01791188 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01008595 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00738691 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.00127635 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99718323 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96797392 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96532499 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95907036 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95301829 |
| 96 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92417163 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92394178 |
| 98 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92336676 |
| 99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91572752 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91438998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.13628972 |
| 2 | MP0008004_abnormal_stomach_pH | 4.02146107 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 3.58062422 |
| 4 | MP0003303_peritoneal_inflammation | 3.57925507 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.19899941 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 3.08432533 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.98214626 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.97646793 |
| 9 | MP0005171_absent_coat_pigmentation | 2.79301590 |
| 10 | MP0002736_abnormal_nociception_after | 2.55322316 |
| 11 | MP0003724_increased_susceptibility_to | 2.45112205 |
| 12 | MP0003136_yellow_coat_color | 2.21124798 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.20054112 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.20054112 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.16747013 |
| 16 | MP0005410_abnormal_fertilization | 2.09614220 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.02251238 |
| 18 | MP0005083_abnormal_biliary_tract | 1.98847485 |
| 19 | MP0001188_hyperpigmentation | 1.90796161 |
| 20 | MP0000230_abnormal_systemic_arterial | 1.86674834 |
| 21 | MP0004510_myositis | 1.86567615 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.80994011 |
| 23 | MP0008872_abnormal_physiological_respon | 1.79449255 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.76187536 |
| 25 | MP0001661_extended_life_span | 1.73260131 |
| 26 | MP0001664_abnormal_digestion | 1.66497671 |
| 27 | MP0004130_abnormal_muscle_cell | 1.63642358 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.61164045 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.58130117 |
| 30 | MP0002398_abnormal_bone_marrow | 1.51663026 |
| 31 | MP0009278_abnormal_bone_marrow | 1.51468956 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.41938302 |
| 33 | MP0000343_altered_response_to | 1.40158261 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.38567421 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.34387129 |
| 36 | MP0009697_abnormal_copulation | 1.30083163 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.26866412 |
| 38 | MP0001663_abnormal_digestive_system | 1.26787834 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.22875225 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.19451313 |
| 41 | MP0001756_abnormal_urination | 1.19168939 |
| 42 | MP0003638_abnormal_response/metabolism_ | 1.19003286 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.18794937 |
| 44 | MP0005409_darkened_coat_color | 1.14988508 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.14929687 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.12868251 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10643530 |
| 48 | MP0002722_abnormal_immune_system | 1.09790207 |
| 49 | MP0001851_eye_inflammation | 1.09484737 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.09321970 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.08257611 |
| 52 | MP0002429_abnormal_blood_cell | 1.05131991 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.04301429 |
| 54 | MP0001970_abnormal_pain_threshold | 1.02247840 |
| 55 | MP0002723_abnormal_immune_serum | 1.02147155 |
| 56 | MP0008057_abnormal_DNA_replication | 1.01076131 |
| 57 | MP0001765_abnormal_ion_homeostasis | 0.99132784 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 0.98149824 |
| 59 | MP0010368_abnormal_lymphatic_system | 0.97340373 |
| 60 | MP0000490_abnormal_crypts_of | 0.93950099 |
| 61 | MP0002132_abnormal_respiratory_system | 0.93630069 |
| 62 | MP0005671_abnormal_response_to | 0.91543762 |
| 63 | MP0004215_abnormal_myocardial_fiber | 0.88432410 |
| 64 | MP0000716_abnormal_immune_system | 0.88271617 |
| 65 | MP0005501_abnormal_skin_physiology | 0.88212160 |
| 66 | MP0002452_abnormal_antigen_presenting | 0.87474063 |
| 67 | MP0000358_abnormal_cell_content/ | 0.85792540 |
| 68 | MP0004043_abnormal_pH_regulation | 0.85651946 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.85636399 |
| 70 | MP0002420_abnormal_adaptive_immunity | 0.85214108 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 0.84822858 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.83134430 |
| 73 | MP0009642_abnormal_blood_homeostasis | 0.82835683 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.82780335 |
| 75 | MP0001905_abnormal_dopamine_level | 0.82648805 |
| 76 | MP0003763_abnormal_thymus_physiology | 0.81990856 |
| 77 | MP0001819_abnormal_immune_cell | 0.81712331 |
| 78 | MP0000249_abnormal_blood_vessel | 0.81489662 |
| 79 | MP0001800_abnormal_humoral_immune | 0.80498002 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.79820335 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.79278868 |
| 82 | MP0008874_decreased_physiological_sensi | 0.79156583 |
| 83 | MP0003436_decreased_susceptibility_to | 0.78765311 |
| 84 | MP0009763_increased_sensitivity_to | 0.76159091 |
| 85 | MP0000858_altered_metastatic_potential | 0.75911359 |
| 86 | MP0003718_maternal_effect | 0.75463886 |
| 87 | MP0009764_decreased_sensitivity_to | 0.74891155 |
| 88 | MP0003828_pulmonary_edema | 0.74360680 |
| 89 | MP0005025_abnormal_response_to | 0.73018386 |
| 90 | MP0001191_abnormal_skin_condition | 0.72727759 |
| 91 | MP0005535_abnormal_body_temperature | 0.72596466 |
| 92 | MP0003448_altered_tumor_morphology | 0.71179550 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.71120597 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.70900831 |
| 95 | MP0005332_abnormal_amino_acid | 0.68728280 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.67348560 |
| 97 | MP0003866_abnormal_defecation | 0.66550705 |
| 98 | MP0006054_spinal_hemorrhage | 0.62472031 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.62089280 |
| 100 | MP0004947_skin_inflammation | 0.61305228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.86992534 |
| 2 | Petechiae (HP:0000967) | 7.57097555 |
| 3 | Menorrhagia (HP:0000132) | 7.49817943 |
| 4 | Increased mean platelet volume (HP:0011877) | 7.38441003 |
| 5 | Dyschromatopsia (HP:0007641) | 6.92811464 |
| 6 | Abnormal platelet volume (HP:0011876) | 6.92364258 |
| 7 | Epistaxis (HP:0000421) | 6.79278992 |
| 8 | Purpura (HP:0000979) | 6.35140942 |
| 9 | Gingival bleeding (HP:0000225) | 5.49397096 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.94142664 |
| 11 | Impaired platelet aggregation (HP:0003540) | 4.81116335 |
| 12 | Abnormal platelet function (HP:0011869) | 4.81116335 |
| 13 | Decreased central vision (HP:0007663) | 4.18526974 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.98606802 |
| 15 | Joint hemorrhage (HP:0005261) | 3.77780238 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65057370 |
| 17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.59390607 |
| 18 | Acanthocytosis (HP:0001927) | 3.54839007 |
| 19 | Spontaneous abortion (HP:0005268) | 3.52937276 |
| 20 | Poikilocytosis (HP:0004447) | 3.51066701 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 3.34015243 |
| 22 | Increased IgM level (HP:0003496) | 3.04747210 |
| 23 | Exertional dyspnea (HP:0002875) | 3.00811202 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.98813412 |
| 25 | Bruising susceptibility (HP:0000978) | 2.84695948 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 2.83455463 |
| 27 | Paralysis (HP:0003470) | 2.75257089 |
| 28 | Testicular atrophy (HP:0000029) | 2.72567544 |
| 29 | Abnormal pupillary function (HP:0007686) | 2.72488794 |
| 30 | Tinnitus (HP:0000360) | 2.71149115 |
| 31 | Hypophosphatemic rickets (HP:0004912) | 2.70521831 |
| 32 | Facial diplegia (HP:0001349) | 2.69041497 |
| 33 | Conjunctival telangiectasia (HP:0000524) | 2.66388271 |
| 34 | Thrombocytosis (HP:0001894) | 2.58469872 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.50118874 |
| 36 | Congenital stationary night blindness (HP:0007642) | 2.47466658 |
| 37 | Choroideremia (HP:0001139) | 2.45542450 |
| 38 | Abnormality of renal resorption (HP:0011038) | 2.42770707 |
| 39 | Rib fusion (HP:0000902) | 2.39110295 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37046409 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.35668781 |
| 42 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.34881885 |
| 43 | Rectovaginal fistula (HP:0000143) | 2.32764430 |
| 44 | Rectal fistula (HP:0100590) | 2.32764430 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.27715701 |
| 46 | Male infertility (HP:0003251) | 2.25959621 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20989179 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.20606157 |
| 49 | Mesangial abnormality (HP:0001966) | 2.19707938 |
| 50 | Facial hemangioma (HP:0000329) | 2.15491653 |
| 51 | Arterial thrombosis (HP:0004420) | 2.14651323 |
| 52 | Abnormality of iron homeostasis (HP:0011031) | 2.14094712 |
| 53 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.14026263 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08390803 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.07540557 |
| 56 | Abnormality of the hepatic vasculature (HP:0006707) | 2.06518932 |
| 57 | Abnormality of lateral ventricle (HP:0030047) | 2.01271085 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 2.00526225 |
| 59 | Vaginal fistula (HP:0004320) | 1.99027827 |
| 60 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94757752 |
| 61 | Intestinal fistula (HP:0100819) | 1.94456739 |
| 62 | Muscle fiber atrophy (HP:0100295) | 1.93680775 |
| 63 | Joint swelling (HP:0001386) | 1.93229283 |
| 64 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.92877447 |
| 65 | Absent/shortened dynein arms (HP:0200106) | 1.92877447 |
| 66 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92707251 |
| 67 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92158301 |
| 68 | Amaurosis fugax (HP:0100576) | 1.84584340 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 1.83754615 |
| 70 | Abnormal ciliary motility (HP:0012262) | 1.83407744 |
| 71 | Abnormality of the prostate (HP:0008775) | 1.83365883 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79702151 |
| 73 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79702151 |
| 74 | Annular pancreas (HP:0001734) | 1.79343351 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77892671 |
| 76 | Stomatitis (HP:0010280) | 1.75904208 |
| 77 | Central scotoma (HP:0000603) | 1.75748003 |
| 78 | Poikiloderma (HP:0001029) | 1.74519088 |
| 79 | Abnormality of the costochondral junction (HP:0000919) | 1.69695902 |
| 80 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67558237 |
| 81 | Hypertriglyceridemia (HP:0002155) | 1.66986792 |
| 82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.66255568 |
| 83 | 3-Methylglutaconic aciduria (HP:0003535) | 1.65472210 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.65423388 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 1.65211498 |
| 86 | Hyperalaninemia (HP:0003348) | 1.65211498 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65211498 |
| 88 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65208709 |
| 89 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.64387150 |
| 90 | Thrombophlebitis (HP:0004418) | 1.64172377 |
| 91 | Long clavicles (HP:0000890) | 1.63844129 |
| 92 | Increased density of long bones (HP:0006392) | 1.62486264 |
| 93 | Metaphyseal dysplasia (HP:0100255) | 1.61055355 |
| 94 | Chest pain (HP:0100749) | 1.60971244 |
| 95 | Atrioventricular block (HP:0001678) | 1.59707650 |
| 96 | Chorioretinal atrophy (HP:0000533) | 1.58970359 |
| 97 | Fetal akinesia sequence (HP:0001989) | 1.57276695 |
| 98 | Chronic otitis media (HP:0000389) | 1.56581062 |
| 99 | Biliary tract neoplasm (HP:0100574) | 1.56069284 |
| 100 | Thin bony cortex (HP:0002753) | 1.55126380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMX | 3.40840928 |
| 2 | MST4 | 3.38562224 |
| 3 | RIPK4 | 3.17664726 |
| 4 | TEC | 3.06001172 |
| 5 | BTK | 2.84806402 |
| 6 | MAPK15 | 2.77309231 |
| 7 | TESK2 | 2.71159008 |
| 8 | MYLK | 2.57716874 |
| 9 | TAOK3 | 2.47753885 |
| 10 | ZAP70 | 2.28306863 |
| 11 | FES | 2.21200770 |
| 12 | EIF2AK1 | 2.13884616 |
| 13 | CSF1R | 2.08080146 |
| 14 | BCKDK | 2.01232795 |
| 15 | SYK | 1.94131854 |
| 16 | ACVR1B | 1.91541642 |
| 17 | MAP2K3 | 1.83385958 |
| 18 | WNK4 | 1.82319099 |
| 19 | PBK | 1.76468532 |
| 20 | GRK6 | 1.70529930 |
| 21 | GRK5 | 1.67494155 |
| 22 | ADRBK2 | 1.64309496 |
| 23 | NUAK1 | 1.63585720 |
| 24 | PIK3CG | 1.61320004 |
| 25 | PTK2B | 1.55588996 |
| 26 | KDR | 1.53558207 |
| 27 | HCK | 1.51496271 |
| 28 | STK3 | 1.47890734 |
| 29 | ZAK | 1.46018538 |
| 30 | ILK | 1.38740665 |
| 31 | SCYL2 | 1.38232148 |
| 32 | BLK | 1.36022262 |
| 33 | CDC7 | 1.33025545 |
| 34 | TXK | 1.25277629 |
| 35 | TNK2 | 1.21682155 |
| 36 | TLK1 | 1.18606001 |
| 37 | ITK | 1.18360196 |
| 38 | DAPK2 | 1.12439796 |
| 39 | BMPR2 | 1.12262242 |
| 40 | ADRBK1 | 1.10151310 |
| 41 | IKBKB | 1.09456150 |
| 42 | VRK1 | 1.08363961 |
| 43 | LYN | 1.08068637 |
| 44 | PAK1 | 1.02568109 |
| 45 | FLT3 | 0.99616708 |
| 46 | DAPK3 | 0.99580142 |
| 47 | VRK2 | 0.96326637 |
| 48 | MUSK | 0.92994614 |
| 49 | PIM2 | 0.92352971 |
| 50 | BRSK2 | 0.91401011 |
| 51 | MATK | 0.90545610 |
| 52 | DAPK1 | 0.89191942 |
| 53 | MAP3K5 | 0.88313013 |
| 54 | MAPK12 | 0.86057897 |
| 55 | CCNB1 | 0.82279772 |
| 56 | BMPR1B | 0.81434047 |
| 57 | PRKD1 | 0.80429195 |
| 58 | TAOK2 | 0.77961494 |
| 59 | CAMKK2 | 0.70192224 |
| 60 | PKN1 | 0.67091066 |
| 61 | LMTK2 | 0.66409728 |
| 62 | MARK3 | 0.66155516 |
| 63 | MAP2K6 | 0.64424685 |
| 64 | PRKCQ | 0.64002990 |
| 65 | SIK3 | 0.63256687 |
| 66 | LCK | 0.56641673 |
| 67 | PHKG1 | 0.55868856 |
| 68 | PHKG2 | 0.55868856 |
| 69 | KIT | 0.54451429 |
| 70 | MAPKAPK3 | 0.54376977 |
| 71 | PRKG2 | 0.53011811 |
| 72 | IRAK1 | 0.52460154 |
| 73 | MAP4K1 | 0.51027989 |
| 74 | TRIM28 | 0.49461898 |
| 75 | STK4 | 0.48445241 |
| 76 | FER | 0.47810658 |
| 77 | FGR | 0.47201926 |
| 78 | GRK1 | 0.46860182 |
| 79 | EIF2AK2 | 0.46249274 |
| 80 | DYRK1B | 0.45892777 |
| 81 | PLK2 | 0.45442726 |
| 82 | MAP3K11 | 0.44629304 |
| 83 | PRKCD | 0.43279166 |
| 84 | AURKA | 0.40746053 |
| 85 | MAP3K6 | 0.40168122 |
| 86 | EIF2AK3 | 0.40160221 |
| 87 | RET | 0.39923232 |
| 88 | PRKCA | 0.39638306 |
| 89 | CSK | 0.38844787 |
| 90 | IRAK2 | 0.38181599 |
| 91 | MINK1 | 0.37982402 |
| 92 | PDPK1 | 0.36787111 |
| 93 | CDK14 | 0.35886035 |
| 94 | PRKACG | 0.35193134 |
| 95 | HIPK2 | 0.34767743 |
| 96 | ERBB2 | 0.34337896 |
| 97 | DYRK3 | 0.31411969 |
| 98 | MAPK13 | 0.28953148 |
| 99 | STK39 | 0.28170314 |
| 100 | JAK3 | 0.26338401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.19007148 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.98325973 |
| 3 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.75862975 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.53077994 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.46629918 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.39556919 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.32657761 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.29286755 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.22722938 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14771841 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.98185912 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84274701 |
| 13 | Gap junction_Homo sapiens_hsa04540 | 1.68511014 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.67599594 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64783792 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57796220 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55098748 |
| 18 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.50074124 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49569679 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40377727 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33384551 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32370016 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32166568 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29944152 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29919282 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25482049 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25432338 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23791666 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13975470 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13234743 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11826459 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.10570953 |
| 33 | Alcoholism_Homo sapiens_hsa05034 | 1.09689181 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07423946 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05253102 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04680925 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01137965 |
| 38 | Asthma_Homo sapiens_hsa05310 | 0.99452278 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 0.99298165 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99261054 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98086883 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97926036 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.94841417 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 0.94047462 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 0.93718434 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 0.91890411 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.90298461 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88027889 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85074673 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84901202 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.81764672 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81083762 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80208533 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78715578 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78509795 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77460586 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77026137 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76697376 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75429924 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70348425 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68698527 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66907755 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66891604 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66324635 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62634169 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60683729 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.59296673 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.58825833 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56147829 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54019164 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53983263 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.51330249 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.50870825 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50390458 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50012594 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48662714 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47986758 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47924123 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.47290259 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.43401317 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43333475 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42757716 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42059941 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41992174 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41925190 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41580998 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41521111 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.40566366 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38772181 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38601187 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31995218 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31186062 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31007251 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30778545 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30347613 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29550180 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29314316 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.28974214 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27248406 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26856365 |

